Event Details
Future relative to document
Description
Initial Closing
Participants (2)
| Name | Type | Mentions | |
|---|---|---|---|
| General Partner | person | 93 | View Entity |
| A group of limited partners | person | 36 | View Entity |
Source Documents (1)
HOUSE_OVERSIGHT_024057.jpg
This document is a page from a confidential offering memorandum for 'New Leaf Ventures III, L.P.', a healthcare and life sciences investment fund targeting $375 million in capital. It outlines the partnership structure, appointing New Leaf Venture Associates III, L.P. as the General Partner and listing five managing principals (Chambon, Delagardelle, Hunt, Lathi, and Ratcliffe). The document bears a House Oversight Committee stamp, indicating it was part of a congressional investigation document production.
Related Events
Events with shared participants
Closing of the offering
Date unknown • Unspecified
End of primary illiquidity period; Board must determine whether to pursue a sale or Initial Listing.
Date unknown • N/A
No Fault Termination of Investment Period
Date unknown
Final Closing Date
2025-11-12 • Not specified
Dissolution of KUE
Date unknown • N/A
Dissolution of the Fund
Date unknown
First closing of the offering
Date unknown
Discussion 0
No comments yet
Be the first to share your thoughts on this epstein event